Hong Kong tech startup will advance AI lung cancer screening project to help fight the city's top cancer killers

AI News


Hong Kong, October 4, 2025 /PRNewswire/ -Hong Kong Science Park-based local high-tech startup Caretia today announced that its AI-powered lung cancer screening platform has reached an early milestone and has entered a new phase of development. This progress is based on the CEO Mr. John Lee The government has indicated that it specifically recommends comprehensively strengthening cancer prevention and diagnosis, particularly starting AI-assisted lung cancer screenings.

CARETIA AI Medical Imaging Platform
CARETIA AI Medical Imaging Platform

Lung cancer remains one of the most common cancers, according to data from the HK Cancer Online Resource Hub Hong Kong It is the main cause of cancer-related deaths. A core challenge contributing to high mortality is that early stage lung cancer does not present generally clear symptoms. By the time symptoms appear, the condition is often progressing to a middle or advanced stage. Although low-dose computed tomography is internationally recognized as an effective method for early detection, widespread adoption in screening programs still faces practical challenges.

Caretia's team consisting of graduate research students and graduates from University of Hong Kong and Hong Kong China University Fields including medicine and computer science have been developing and improving AI models for the past year to improve screening efficiency and reduce costs. The company also partners with local charities to subsidize lung health screening in underprivileged communities. Hong Kong. This initiative not only provides important early screening for those in need, but also generates valuable and locally relevant clinical data to further improve the accuracy of AI models. Hong Kong population.

“We are greatly encouraged by welcoming modern policy addresses and focusing on leveraging the use of AI technology to enhance cancer screening and diagnosis,” he said. Philip Zanco-founder and CEO of Caretia. “Ongoing R&D in AI-assisted CT scan analysis is designed to proactively identify early stage lesions. If lung cancer can be detected and treated early stages, patient recovery rates can be significantly improved and public and private healthcare costs can be significantly reduced.”

Philip also said, “As a technical team on the local route, we are ready to contribute to the healthcare sector and look forward to uniting. Hong Kong It promotes the finest innovative talent and close cooperation between government health authorities, academic institutions and the scientific research community, building a collectively healthy future. ”



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *